New Systemic Therapies for the Treatment of Advanced Non-Melanoma Skin Cancers: Which of Your Patients May Benefit?

Monday, January 23, 2023

6:00 PM – 7:00 PM EST Presentation
5:00 PM – 6:00 PM CT
4:00 PM – 5:00 PM MT
3:00 PM – 4:00 PM PT

Program Features:

  • Interactive, case-based learning environment
  • Downloadable Whiteboard Animations
  • Create your own Personalized Poster

Program Description

This live activity will investigate the critical role of systemic therapy – including targeted treatment and immunotherapy – in patients with advanced non-melanoma skin cancers (NMSCs) who fail or are ineligible for surgical or radiation therapy. Learners will be able to compare and contrast current and emerging systemic treatment options, describe factors that can help determine when systemic therapy is appropriate, and implement elements of multidisciplinary care to enhance the clinical management of NMSC.

Learning Objectives

After completing the CME activity, learners should be better able to:

  • Justify the use of new systemic therapies with different mechanisms of action for the treatment of patients with advanced NMSCs failing or not amenable to surgery or radiation
  • Recommend approaches to identify and mitigate side effects associated with the mechanisms of action of new systemic therapies for the treatment of patients with advanced NMSCs
  • Incorporate risk stratification into routine clinical practice in order to identify patients who may benefit from new systemic therapies for the treatment of advanced NMSCs
  • Design management plans in conjunction with interdisciplinary care-based teams for patients with advanced NMSCs not amenable to surgery or radiation

Target Audience

This activity is designed to meet the educational needs of dermatologists, oncologists, and the multidisciplinary care team who care for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas.

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

Physician Credit Designation Statement

Med Learning Group designates this live virtual activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing (ANCC) Credit Designation

Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. educational activity.

Disclosure Of Unlabeled Use

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

Disclaimer

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: https://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com